Abstract: Techniques are provided for block-level fail atomicity on byte-level non-volatile media. In one technique, an offset table and application data that stores content of a file are stored for a file. The offset table includes multiple entries, each entry being associated with a different offset value and storing a logical block address (LBA) that references a location in the application data. In response to receiving a request, that includes an input buffer and an offset value, to update the file: (a) an entry, in the offset table, that corresponds to the offset value and comprises a first LBA is identified; (b) a second LBA that is considered free is identified; (c) the second LBA is replaced with the first LBA; (d) the input buffer is written to a location, in the application data, that the second LBA references; and (e) the second LBA is added in the entry.

Abstract: Techniques are provided for block-level fail atomicity on byte-level non-volatile media. In one technique, an offset table and application data that stores content of a file are stored for a file. The offset table includes multiple entries, each entry being associated with a different offset value and storing a logical block address (LBA) that references a location in the application data. In response to receiving a request, that includes an input buffer and an offset value, to update the file: (a) an entry, in the offset table, that corresponds to the offset value and comprises a first LBA is identified; (b) a second LBA that is considered free is identified; (c) the second LBA is replaced with the first LBA; (d) the input buffer is written to a location, in the application data, that the second LBA references; and (e) the second LBA is added in the entry.

Abstract: Disclosed are hybrid wound dressings that include at least one front layer of a hydrophilic absorbent material and at least one layer behind the front layer that is made of an open-celled polymeric foam made from high internal phase emulsions (HIPEs). The hydrophilic absorbent material may be a natural polymeric material; a synthetic, non-foam polymer; or a material like glass microfiber. Each layer has a rate of fluid absorption and a capillary suction pressure (CSP) for a working fluid like blood plasma. The CSP increases from the front layer toward the layers behind the front layer, such that fluid is drawn away from a wound.

Abstract: Disclosed are hybrid wound dressings that include at least one front layer of a hydrophilic absorbent material and at least one layer behind the front layer that is made of an open-celled polymeric foam made from high internal phase emulsions (HIPEs). The hydrophilic absorbent material may be a natural polymeric material; a synthetic, non-foam polymer; or a material like glass microfiber. Each layer has a rate of fluid absorption and a capillary suction pressure (CSP) for a working fluid like blood plasma. The CSP increases from the front layer toward the layers behind the front layer, such that fluid is drawn away from a wound.

Abstract: Disclosed are methods for using open-celled polymeric foam wound dressings made from high internal phase emulsions (HIPEs). The wound dressings have a high capillary pressure and may reduce or obviate the need for treatments like negative pressure wound treatment (NPWT). Also disclosed are structures for HIPE foam wound dressings. The HIPE foam wound dressings typically include at least two layers of HIPE foam with different, but homogeneous, average cell sizes. The average cell sizes form a cell size gradient, with cell size typically decreasing from the front or face layer of foam toward the back layer of foam. The back layer of foam may be a collapsed layer, while the front layer or layers may be expanded. Compared with HIPE foams for other absorbent applications, the wound dressing foams may be higher in hydratable salts and higher in initial moisture levels.

Abstract: Disclosed are methods for using open-celled polymeric foam wound dressings made from high internal phase emulsions (HIPEs). The wound dressings have a high capillary pressure and may reduce or obviate the need for treatments like negative pressure wound treatment (NPWT). Also disclosed are structures for HIPE foam wound dressings. The HIPE foam wound dressings typically include at least two layers of HIPE foam with different, but homogeneous, average cell sizes. The average cell sizes form a cell size gradient, with cell size typically decreasing from the front or face layer of foam toward the back layer of foam. The back layer of foam may be a collapsed layer, while the front layer or layers may be expanded. Compared with HIPE foams for other absorbent applications, the wound dressing foams may be higher in hydratable salts and higher in initial moisture levels.

Abstract: The present invention relates to a shaving kit that comprises a first personal care article, a second personal care article and a shaving razor. The first personal care article comprises a personal care composition contained within a package. The personal care composition comprises a surfactant, water and at least 15% of a hydrophobic moisturizing material. The second personal care article comprises an in-shower body lotion composition contained in a package; and a set of instructions in association with the package. The set of instructions comprising instructions to dispense the in-shower body lotion composition from the package, contact the skin surface with the in-shower body lotion composition during showering or bathing, rinse the skin surface, and dry the skin surface. The present invention relates to a method of shaving and a personal care article.

Abstract: Allergen neutralization compositions for use on inanimate objects having an effective amount of an allergy neutralizing aluminum ion, and a solvent. The allergen neutralization compositions are sprayable, and at least about 60%, by weight of the aluminum ion is provided as a salt of an anion selected from the group consisting of sulfate, chloride, nitrite, potassium sulfate and mixtures thereof. The composition preferably contains essentially no aluminum chlorohydarate, and may contain additional allergen denaturing compounds such as polyphenol compounds, hydrogen peroxide, salicylic acid, citric acid, lactic acid, glycolic acid, additional metal ions and mixtures of these. Other optional ingredients include film forming polymers to control the allergen containing dust. These allergen neutralization compositions provide excellent efficacy against various allergens, and specifically, the allergens associated with house dust mites and other common allergens such as cat dander, pollen and the like.

Abstract: Disclosed are pharmaceutical compositions comprising a radical scavenging agent and an anti-inflammatory agent which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of a radical scavenging agent, an anti-inflammatory agent, and a sunscreen are also disclosed.Also disclosed is a method for using these compositions topically to prevent damage to skin caused by acute or chronic UV exposure.

Abstract: The present invention involves photoprotective compositions which are useful for topical application to prevent damage to skin caused by acute or chronic exposure to ultraviolet light comprising chelating agents. Also involved are compositions comprising chelating agents together with anti-inflammatory agents, sunscreening agents, and/or radical scavenging agents. Methods for using such compositions to prevent damage to skin caused by acute or chronic exposure to ultraviolet light are also involved.

Abstract: The present invention provides deodorant compositions for controlling malodor from perspiration comprising a safe an effective amount of a 1,3-diketone compound having the general formula: ##STR1## wherein each W is independently selected from the group consisting of O, S and (CH.sub.2).sub.n, wherein n=1-3; and each X is independently selected from the group consisting of hydrogen, halogen, substituted or unsubstituted alkyl having from about 1 to about 5 carbon atoms, or two X moieties are covalently bonded to form a substituted or unsubstituted alkyl, heteroalkyl, aryl or heteroaryl ring having from about 3 to about 12 atoms including from 0 to about 3 heteroatoms in the ring; and a topical carrier; whereby the composition is suitable for topical application to the skin or to articles of clothing worn in the vicinity of the skin.

Abstract: Disclosed are photoprotective compositions comprising a radical scavenging agent and an anti-inflammatory agent which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of a radical scavenging agent, an anti-inflammatory agent, and a sunscreen are also disclosed.Also disclosed is a method for using these compositions topically to prevent damage to skin caused by acute or chronic UV exposure.

Abstract: The present invention involves photoprotective compositions which are useful for topical application to prevent damage to skin caused by acute or chronic exposure to ultraviolet light comprising chelating agents having the formula ##STR1## wherein --R.sup.1 and --R.sup.2 are independently selected from the group consisting of alkyl, aryl, and heteroaryl, or R.sup.1 and R.sup.2 may be covalently bonded together to form a cyclic alkyl; --M is selected from the group consisting of =0, =S, --SR.sup.4 and --OR.sup.4 (when --M is --OR.sup.4 or --SR.sup.4, there is a hydrogen bonded to the carbon to which --M is bonded); --R.sup.4 is selected from the group consisting of hydrogen, alkyl, aryl and heteroaryl; --R.sup.3 is selected from the group consisting of hydrogen, alkyl, aryl and heteroaryl; --R.sup.6 is selected from the group consisting of hydrogen alkyl, aryl and heteroaryl; and i is selected from the group consisting of one and zero.

Abstract: The present invnetion relates to a compositon for topical application for regulating wrinkles in mammalian skin comprising a benzofuran derivative having the structure ##STR1## wherein R.sup.1 and R.sup.2 are each independently methyl or ethyl, R.sup.3 is C.sub.1 -C.sub.4 alkyl, y is an integer from 1 to about 3 and each X is independently selected from the group consisting of Cl, Br, I, F, NO.sub.3, NO.sub.4, SO.sub.3 and SO.sub.4, and a safe and effective amount of a topical carrier.

Abstract: Disclosed are pharmaceutical compositions comprising tocopherol sorbate and an anti-inflammatory agent which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of tocopherol sorbate, an anti-inflammatory agent, and a sunscreen are also disclosed.Also disclosed is a method for using these compositions topically to prevent damage to skin caused by acute or chronic UV exposure.

Abstract: Disclosed are pharmaceutical compositions comprising sorbohydroxamic acid, or pharmaceutically-acceptable salts thereof, and an anti-inflammatory agent, which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of sorbohydroxamic acid and an anti-inflammatory agent together with tocopherol sorbate and/or sunscreens are also disclosed.Also disclosed is a method for using these compositions topically to prevent damage to skin caused by acute or chronic UV exposure.

Abstract: Disclosed are pharmaceutical compositions comprising sorbohydroxamic acid, or pharmaceutically-acceptable salts thereof, which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of sorbohydroxamic acid together with tocopherol sorbate and/or sunscreens are also disclosed.Also disclosed is a method for using these compositions topically, prior to UV exposure, to prevent damage to skin caused by acute or chronic UV exposure.

Abstract: Disclosed are pharmaceutical compositions comprising sorbohydroxamic acid, or pharmaceutically-acceptable salts thereof, and an anti-inflammatory agent, which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of sorbohydroxamic acid and an anti-inflammatory agent together with tocopherol sorbate and/or sunscreens are also disclosed.Also disclosed is a method for using these compositions topically to prevent damage to skin caused by acute or chronic UV exposure.

Abstract: Disclosed are pharmaceutical compositions comprising tocopherol sorbate and an anti-inflammatory agent which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of tocopherol sorbate, an anti-inflammatory agent, and a sunscreen are also disclosed.Also disclosed is a method for using these compositions topically to prevent damage to skin caused by acute or chronic UV exposure.